|
GB8822285D0
|
|
Opthalmic preparations
|
|
GB8802391D0
|
|
Medicinal formulations
|
|
GB2067900A
|
|
Medicinal tablets
|
|
GB1475241A
|
|
Benzodiazocine derivatives and pharmaceutical compositions containing them
|
|
US4089953A
|
|
1,5-Benzodiazocines
|
|
US4060608A
|
|
Substituted hydroxymethyl benzodiazepines
|
|
GB1479098A
|
|
Benzodiazocine derivatives and pharmaceutical compositions containing them
|
|
NL7507092A
|
|
2-Amino-1,5-benzodiazocines and 5-oxides thereof - having CNS active props
|
|
ZA7503751B
|
|
1,4-benzodiazocine derivatives
|
|
JPS51146488A
|
|
Production of 1*44 benzodiazocine derivatilves
|
|
CH605838A5
|
|
2-Amino-1,5-benzodiazocines and 5-oxides thereof
|
|
CH610893A5
|
|
Process for the preparation of a 1,5-benzodiazocine derivative
|
|
DE2525094A1
|
|
2-Amino-1,5-benzodiazocines and 5-oxides thereof - having CNS active props
|
|
GB1440308A
|
|
Benzodiazepine derivatives
|
|
GB1470865A
|
|
1,4-benzodiazepines
|
|
GB1425159A
|
|
Phenylacetone compounds and their bisulphite adducts
|
|
US4006135A
|
|
Hydroxymethyl benzodiazepine derivatives
|
|
GB1448895A
|
|
Azeto-1,4-benzodiazepines
|
|
GB1448894A
|
|
Benzodiazepines
|
|
GB1413600A
|
|
Quinazoline derivatives
|
